Dr. Carlos Elizondo, M.D.
What this data tells you about Dr. Elizondo
Dr. Carlos Elizondo is a family medicine in Alice, TX, with 12 years in practice. Based on federal Medicare data, Dr. Elizondo performed 7,561 Medicare services across 3,813 unique beneficiaries.
Between the years covered by Open Payments, Dr. Elizondo received a total of $17,312 from 62 pharmaceutical and/or device companies across 1055 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Elizondo is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 1,312 | $83 | $259 |
| Remote patient monitoring device, 30 days | 910 | $35 | $96 |
| Remote patient monitoring management, 20 min/month | 589 | $35 | $80 |
| Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | 463 | $28 | $99 |
| Drug injection, under skin or into muscle | 415 | $10 | $59 |
| Office visit, established patient, complex (40-54 min) | 351 | $128 | $349 |
| Annual wellness visit, follow-up | 324 | $122 | $280 |
| Ceftriaxone antibiotic injection | 279 | $0 | $5 |
| Advance care planning consultation, first 30 min | 262 | $76 | $208 |
| Chronic care management, first 20 min/month | 245 | $46 | $140 |
| Dexamethasone injection (steroid) | 225 | $0 | $25 |
| Annual depression screening | 218 | $17 | $44 |
| Automated urinalysis | 209 | $2 | $15 |
| Injection, ketorolac tromethamine, per 15 mg | 159 | $0 | $25 |
| Nursing facility visit, moderate complexity | 142 | $76 | $222 |
| Office visit, established patient (20-29 min) | 132 | $49 | $176 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 128 | $28 | $80 |
| Nursing facility visit, low complexity | 126 | $47 | $169 |
| Blood glucose (sugar) test performed by hand-held instrument | 109 | $3 | $20 |
| Testing for presence of drug, read by direct observation | 108 | $12 | $17 |
| Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | 107 | $79 | $262 |
| Hemoglobin A1c test (diabetes monitoring) | 89 | $9 | $20 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 80 | $1 | $20 |
| Electrocardiogram (EKG), 12-lead | 79 | $10 | $41 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 78 | $38 | $129 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 70 | $151 | $413 |
| Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 43 | $0 | $10 |
| Inhalation treatment for airway obstruction or sputum production | 36 | $7 | $43 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | 31 | $64 | $118 |
| Flu vaccine administration | 31 | $30 | $60 |
| Annual alcohol misuse screening, 5 to 15 minutes | 31 | $16 | $44 |
| Flu vaccine, high-dose | 29 | $72 | $117 |
| Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | 26 | $47 | $132 |
| New patient office visit (45-59 min) | 25 | $92 | $398 |
| Telephone medical discussion with physician, 21-30 minutes | 23 | $97 | $181 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 19 | $16 | $60 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | 18 | $107 | $367 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 17 | $158 | $395 |
| Electrocardiogram (ecg) 2-day continuous | 12 | $12 | $62 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 11 | $24 | $144 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for family medicine in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Elizondo is a clinical cardiology specialist, with above-average Medicare volume (top 2% in TX), and high industry engagement (low-engagement, top 2%).
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Elizondo experienced with office visit, established patient (30-39 min)?
Does Dr. Elizondo receive payments from pharmaceutical companies?
How do Dr. Elizondo's costs compare to other family medicines in Alice?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology